PHA-Exchange> Fw: [health-vn] WHO AND PARTNERS ACCELERATE FIGHT AGAINST COUNTERFEIT MEDICINES
Claudio
claudio at hcmc.netnam.vn
Fri Nov 17 01:34:55 PST 2006
From: "Vern Weitzel" <vern at coombs.anu.edu.au>
<media at vtn.wpro.who.int>
>
> *News Release WHO/69*
> *15 November 2006*
> *WHO AND PARTNERS ACCELERATE FIGHT AGAINST COUNTERFEIT MEDICINES *
>
> *UP TO 50% OF MEDICINES SOLD THROUGH ROGUE WEB SITES ARE FAKE*
>
> *Geneva -* The World Health Organization (WHO) and more than 20
> international partners are today launching a comprehensive package
> of measures to help national authorities safeguard their populations
> from the dangers of counterfeit medicines.
>
> At the opening of the first official meeting of IMPACT (the
> International Medical Products Anti-Counterfeiting Taskforce) in
> Bonn, WHO and its partners are unveiling a programme covering
> legislation, law enforcement, regulation, technology and
> communication. IMPACT is also issuing a warning against buying
> medicines from rogue web sites as well as cautioning governments
> that existing laws against medical counterfeiters are inadequate and
> do not act as deterrents.
>
> Counterfeit medicines range from products containing no active
> ingredients to those containing highly toxic substances. They can
> harm patients by failing to treat serious conditions, can provoke
> drug resistance and in some cases kill.
>
> The latest estimates jointly elaborated by WHO, the OECD, and the
> Pharmaceutical Security Institute show that more than 30% of
> medicines in some areas of Latin America, South East Asia and
> Sub-Saharan Africa are counterfeit. In emerging economies, the
> proportion is estimated at 10% but in many of the former Soviet
> republics it can be as high as 20%. In wealthy countries, with
> strong regulatory mechanisms, counterfeits account for less than 1%
> of the market value, but 50% of illegal Internet sales are
> counterfeit.
>
> "The impact on people's lives behind these figures is devastating,"
> said Dr Howard Zucker, WHO Assistant Director-General for Health
> Technology and Pharmaceuticals. "Whether rich or poor, many
> patients trustingly taking medicines may end up sicker or die. In
> addition, precious resources spent on these medicines go to waste."
>
> The legal systems of most countries do not consider the
> counterfeiting of medicines a more serious crime than counterfeiting
> luxury items such as handbags or watches. Their laws are designed
> mainly to protect trademarks than people's health. In some
> industrialized countries, counterfeiting t-shirts receives a harsher
> punishment than counterfeiting medicines.
>
> WHO and its IMPACT partners will present guiding principles for
> model legislation to help countries adapt their laws to the gravity
> of the crime. "A major objective is for countries to agree that
> counterfeiting is a crime against human security and incorporate
> that principle into their laws," added Dr Zucker.
>
> Legislation, regulation and enforcement also provide the basis for
> dealing with the sale of counterfeit medicines on the Internet,
> which is already rife in industrialized countries and is growing in
> a number of emerging economies in Latin America and Asia.
>
> Some Internet pharmacies are completely legal operations, set up to
> offer clients convenience and savings. They require patient
> prescriptions and deliver medications from government licensed
> facilities. Other Internet pharmacies operate illegally, selling
> medications without prescriptions and using unapproved or
> counterfeit products. These rogue Internet pharmacies are operated
> internationally, they have no registered business address and sell
> products that have an unknown or unclear origin.
>
> "This area needs more work," said Dr Valerio Reggi, WHO Coordinator
> of IMPACT. "But the message for now is: do not take the risk of
> buying your medicines from unknown sources, such as the Internet. If
> you must buy from the Internet, ensure that the website is that of a
> pharmacy you know and trust."
>
> In the technology area, WHO has launched a challenge to technology
> providers to come up with new technologies or adapt existing ones to
> prevent counterfeiting and detect and track counterfeits on markets
> and on web sites.
>
> WHO is currently looking at proposals from three mobile telephone
> companies to apply their technologies to check the authenticity of
> medical products. DNA-based technologies, nanotechnology and other
> approaches will be assessed by IMPACT in the first quarter of 2007.
>
> To improve communication, a small group has been created to
> continuously update global data on medical counterfeiting and share
> the information with IMPACT partners. In addition, advocacy
> campaigns including public service announcements, short descriptive
> films and other awareness raising materials have begun targeting
> different professional sectors likely to come across the problem of
> counterfeits. Organizations representing health professionals and
> consumers are supporting these initiatives.
>
> Three countries with a high proportion of counterfeits have already
> started tackling the problem with IMPACT's support. Indonesia and
> Mali have begun wide communication campaigns to educate the general
> public on the dangers of counterfeits and to dissuade people seeking
> treatment from buying on the black market. Vietnam is establishing
> mechanisms to coordinate more effectively between regulatory,
> police, customs and provincial authorities in order to improve
> detection of counterfeit medicines and counterfeiters.
>
> "It is clear that action in a single sphere, like legislation or
> technology is not enough to deal effectively with the problem," said
> Dr Reggi. "This is why we need to act on five axes - legal,
> enforcement, regulatory, technology and communication. It's also
> why we need to coordinate action at a global level. But the fact
> that individual countries are already taking this on bodes well for
> the future."
>
> By the end of 2007 IMPACT aims to have all 193 WHO Member States
> formally collaborating to stem global and national counterfeiting of
> medical products.
>
>
>
> *For more facts and figures on medical counterfeiting, see:*
>
> (login: impact1; password: impact2)
>
>
> _http://www.who.int/medicines/services/counterfeit/impact/ImpactF_S/en/index.html_
>
> For more details on IMPACT and a full list of partners see:
>
>
> _http://www.who.int/medicines/services/counterfeit/faqs/count_q-a/en/index.html_
>
> _http://www.who.int/medicines/services/counterfeit/en/index.html_
>
> *Contact: *
>
> Daniela Bagozzi, WHO Media Communications, tel. +41 22 791 45 44;
> mobile +41 79 475 54 90; email: _bagozzid at who.int_
> <mailto:bagozzid at who.int>. All press releases, fact sheets and other
> WHO media material may be found at _www.who.int_ <http://www.who.int>.
>
More information about the PHM-Exchange
mailing list